Literature DB >> 28677096

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

Juan F López-Giménez1, Javier González-Maeso2.   

Abstract

The neuropsychological effects of naturally occurring psychoactive chemicals have been recognized for millennia. Hallucinogens, which include naturally occurring chemicals such as mescaline and psilocybin, as well as synthetic compounds, such as lysergic acid diethylamide (LSD), induce profound alterations of human consciousness, emotion, and cognition. The discovery of the hallucinogenic effects of LSD and the observations that LSD and the endogenous ligand serotonin share chemical and pharmacological profiles led to the suggestion that biogenic amines like serotonin were involved in the psychosis of mental disorders such as schizophrenia. Although they bind other G protein-coupled receptor (GPCR) subtypes, studies indicate that several effects of hallucinogens involve agonist activity at the serotonin 5-HT2A receptor. In this chapter, we review recent advances in understanding hallucinogen drug action through characterization of structure, neuroanatomical location, and function of the 5-HT2A receptor.

Entities:  

Keywords:  5-HT2A receptor; Antipsychotics; G protein-coupled receptor (GPCR); Hallucinogen; Lysergic acid diethylamide (LSD); Mescaline; Psilocin; Psilocybin; Psychedelics; Psychosis; Schizophrenia; Serotonin

Mesh:

Substances:

Year:  2018        PMID: 28677096      PMCID: PMC5756147          DOI: 10.1007/7854_2017_478

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  146 in total

1.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 2.  Reporter-gene systems for the study of G-protein-coupled receptors.

Authors:  S J Hill; J G Baker; S Rees
Journal:  Curr Opin Pharmacol       Date:  2001-10       Impact factor: 5.547

3.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

4.  The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.

Authors:  Z Xia; S J Hufeisen; J A Gray; B L Roth
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice.

Authors:  Hong-Yi Chiu; Ming-Huan Chan; Mei-Yi Lee; Shao-Tsu Chen; Zih-Yi Zhan; Hwei-Hsien Chen
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-24       Impact factor: 5.176

6.  Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.

Authors:  Danuta Marona-Lewicka; Deborah M Kurrasch-Orbaugh; Jennifer R Selken; Medhane G Cumbay; Joshua G Lisnicchia; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2002-07-19       Impact factor: 4.530

Review 7.  Serotonin: a review.

Authors:  L F Mohammad-Zadeh; L Moses; S M Gwaltney-Brant
Journal:  J Vet Pharmacol Ther       Date:  2008-06       Impact factor: 1.786

8.  Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.

Authors:  José L Moreno; Carolina Muguruza; Adrienne Umali; Steven Mortillo; Terrell Holloway; Fuencisla Pilar-Cuéllar; Giuseppe Mocci; Jeremy Seto; Luis F Callado; Rachael L Neve; Graeme Milligan; Stuart C Sealfon; Juan F López-Giménez; J Javier Meana; Deanna L Benson; Javier González-Maeso
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

9.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

10.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more
  28 in total

Review 1.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

2.  Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

Authors:  Alaina M Jaster; Harrison Elder; Samuel A Marsh; Mario de la Fuente Revenga; S Stevens Negus; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2022-03-02       Impact factor: 4.530

Review 3.  Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Authors:  Susan Ling; Felicia Ceban; Leanna M W Lui; Yena Lee; Kayla M Teopiz; Nelson B Rodrigues; Orly Lipsitz; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Kangguang Lin; Roger Ho; Joshua D Rosenblat; David Castle; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-11-17       Impact factor: 5.749

4.  Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).

Authors:  Mathias Ebbesen Jensen; Dea Siggaard Stenbæk; Tobias Søgaard Juul; Patrick MacDonald Fisher; Claus Thorn Ekstrøm; Gitte Moos Knudsen; Anders Fink-Jensen
Journal:  BMJ Open       Date:  2022-10-14       Impact factor: 3.006

Review 5.  Towards an understanding of psychedelic-induced neuroplasticity.

Authors:  Abigail E Calder; Gregor Hasler
Journal:  Neuropsychopharmacology       Date:  2022-09-19       Impact factor: 8.294

6.  Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice.

Authors:  Salvador Sierra; Karan H Muchhala; Donald K Jessup; Katherine M Contreras; Urjita H Shah; David L Stevens; Jennifer Jimenez; Xiomara K Cuno Lavilla; Mario de la Fuente Revenga; Kumiko M Lippold; Shanwei Shen; Justin L Poklis; Liya Y Qiao; William L Dewey; Hamid I Akbarali; M Imad Damaj; Javier González-Maeso
Journal:  Neuropharmacology       Date:  2022-02-17       Impact factor: 5.273

Review 7.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162

Review 8.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

9.  LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice.

Authors:  Kenneth Alper; Bin Dong; Relish Shah; Henry Sershen; K Yaragudri Vinod
Journal:  Front Pharmacol       Date:  2018-08-31       Impact factor: 5.810

10.  The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines.

Authors:  Federico Zamberlan; Camila Sanz; Rocío Martínez Vivot; Carla Pallavicini; Fire Erowid; Earth Erowid; Enzo Tagliazucchi
Journal:  Front Integr Neurosci       Date:  2018-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.